Abiopharma

Mobileye Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Mobileye Global Inc. - MBLY

CCOI Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Cogent Communications Holdings, Inc. – CCOI

Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENPH

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

Sharpen Your Knives: It’s the Final Round of Northern California’s Battle of the Blades

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

Dream Finders Homes named the Official Home Builder of the Tampa Bay Rays and Tampa Bay Rowdies

Mattel Presents at 2026 UBS Global Consumer and Retail Conference to Discuss Strategy and Outlook

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Trip.com Group Limited Securities Fraud Class Action Result of Antitrust Probe and 19% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC